Peter Attia· MD
it's not trivial but we standardly do it for HIV for Zika for dengue in a laboratory and we'll soon be doing it for the new corona virus
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
it's not trivial but we standardly do it for HIV for Zika for dengue in a laboratory and we'll soon be doing it for the new corona virus
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
it requires and you're incubating the patient's plasma or serum with the actual virus then plating it out over cells and then watching the virus infect the cells over the next 2 3 4 5 6 days depending on the virus so what you're looking for is a serum that will block the virus of interest from infecting the sounds